Member Exclusive

Chronic heart failure clinical trial: mesenchymal stem cell therapy safety & viability reported

A Phase IIa clinical trial utilizing intravenous administration of mesenchymal stem cells in cardiac patients has reported positive safety and efficacy results.

Go to the profile of RegMedNet
Sep 02, 2016
0
0

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.

Register

No comments yet.